Operating Lease, Right-of-Use Asset in USD of Propanc Biopharma, Inc. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Propanc Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q3 2019 to Q3 2025.
  • Propanc Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $56.3K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $56.3K 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $59.4K +$41.6K +234% 30 Jun 2025 10-Q 14 Nov 2025
Q1 2025 $62.1K 04 May 2025 10-Q 14 Nov 2025
Q2 2024 $17.8K 30 Jun 2024 10-K 29 Sep 2025
Q1 2023 $44.5K 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $50.7K 31 Dec 2022 10-Q 10 Feb 2023
Q3 2022 $53K 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $62.5K 30 Jun 2022 10-Q 15 May 2023
Q1 2021 $2.4K -$22.6K -90.4% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $9.7K -$25.7K -72.6% 31 Dec 2020 10-Q 12 Feb 2021
Q3 2020 $15.8K -$24.5K -60.8% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 $21.7K 30 Jun 2020 10-K 28 Sep 2021
Q1 2020 $25K 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $35.4K 31 Dec 2019 10-Q 14 Feb 2020
Q3 2019 $40.3K 30 Sep 2019 10-Q 14 Nov 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.